XML 55 R44.htm IDEA: XBRL DOCUMENT

COMMON STOCK AND EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2023

Schedule of computation of earnings per share

The following is a reconciliation of basic and diluted earnings per common share for each of the periods presented (in thousands, except share and per share data):


	Three Months Ended				Nine Months Ended
	September 30, 2023		September 30, 2022		September 30, 2023		September 30, 2022
Basic and Diluted Earnings:
Net Income (Loss) Attributable to Common Stockholders, Used in Basic EPS	$	1,491	$	3,622	$	(5,092)	$	2,651
Add Back: Effect of Dilutive Interest Related to 2025 Notes ⁽¹⁾		—		539		—		—
Net Income (Loss) Attributable to Common Stockholders, Used in Diluted EPS	$	1,491	$	4,161	$	(5,092)	$	2,651

Basic and Diluted Shares:
Weighted Average Shares Outstanding, Basic		22,484,561		18,386,435		22,556,642		18,044,299
Common Shares Applicable to Dilutive Effect of 2025 Notes ⁽²⁾		—		3,119,025		—		—
Weighted Average Shares Outstanding, Diluted		22,484,561		21,505,460		22,556,642		18,044,299

Per Share Information:
Net Income (Loss) Attributable to Common Stockholders
Basic	$	0.07	$	0.20	$	(0.23)	$	0.15
Diluted	$	0.07	$	0.19	$	(0.23)	$	0.15

⁽¹⁾

As applicable, includes interest expense, amortization of discount, amortization of fees, and other changes in net income or loss that would result from the assumed conversion of the 2025 Convertible Senior Notes to derive FFO (as defined herein) effective January 1, 2022 due to the implementation of ASU 2020-06 which requires presentation on an if-converted basis. For the three and nine months ended September 30, 2023, a total of $0.5 million and $1.6 million of interest was not included, respectively, as the impact of the 2025 Notes, if-converted, would have been antidilutive to net income (loss) attributable to common stockholders for the respective periods. For the three months ended September 30 2022, a total of $0.5 million was included as the impact to earnings per share, if-converted, would have been dilutive to net income attributable to common stockholders for the period. For the nine months ended September 30, 2022, the impact of $1.6 million was not included as the impact to earnings per share, if-converted, would have been antidilutive to net income attributable to common stockholders for the period.

⁽²⁾

A total of 3.4 million and 3.3 million shares, representing the dilutive impact of the 2025 Notes, upon adoption of ASU 2020-06 effective January 1, 2022, were not included in the computation of diluted net income (loss) attributable to common stockholders for each of the three and nine month periods ended September 30, 2023, respectively, because they were antidilutive to net income (loss) attributable to common stockholders for the respective periods. A total of 3.1 million shares, representing the dilutive impact of the 2025 Notes, upon adoption of ASU 2020-06 effective January 1, 2022, were included in the computation of diluted net income per share attributable to common stockholders for the three months ended September 30, 2022, because they were dilutive to net income attributable to common stockholders for the period. A total of 3.1 million shares, representing the dilutive impact of the 2025 Notes, were not included in the computation of diluted net income per share attributable to common stockholders for the nine months ended September 30, 2022, because they were antidilutive to net income attributable to common stockholders for the period.